VV
Veena Vikas Kulkarni
About Veena Vikas Kulkarni
Data last updated:
Veena Vikas Kulkarni has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Vv Ent & Endoscopy Hospital Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vv Ent & Endoscopy Hospital Private Limited at ₹1.74 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vv Ent & Endoscopy Hospital Private Limited U85100PN2013PTC146805 | Director | 02 Apr 2013 | 2013 | ₹1.74 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Veena Vikas Kulkarni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veena Vikas Kulkarni
Veena Vikas Kulkarni has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Vv Ent & Endoscopy Hospital Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vv Ent & Endoscopy Hospital Private Limited at ₹1.74 Cr (FY 2024).
Veena Vikas Kulkarni is associated with 1 company as Director, including Vv Ent & Endoscopy Hospital Private Limited (₹1.74 Cr).
Veena Vikas Kulkarni has expertise in General Business.
Veena Vikas Kulkarni has 13 years in corporate governance.
By reported revenue, the largest current company of Veena Vikas Kulkarni is Vv Ent & Endoscopy Hospital Private Limited, with revenue of ₹1.74 Cr (FY 2024).
Veena Vikas Kulkarni currently holds positions at 1 company: Vv Ent & Endoscopy Hospital Private Limited (₹1.74 Cr).